PBS addition expands access to PrEP
As leaders in HIV medicine, Alfred Health welcomes the Federal Government’s decision to improve access to Pre-Exposure Prophylaxis (PrEP) as a significant step forward in preventive public health.
Visitor information – Everything you need to know about visiting our sites.
As leaders in HIV medicine, Alfred Health welcomes the Federal Government’s decision to improve access to Pre-Exposure Prophylaxis (PrEP) as a significant step forward in preventive public health.
Victoria’s largest study into HIV prevention medication will expand into Tasmania following funding from the Tasmania Department of Health, the study begins next Monday 25 September.
Alfred Health’s highly successful PrEPX study will be expanded into South Australia thanks to a new partnership with South Australian Health and Medical Research Institute (SAHMRI) and SA Health.
The Alfred's PrEPX Study will be available to an additional 600 people, thanks to a $100,000 funding boost from the Victorian AIDS Council (VAC).
The Alfred's ground-breaking study providing people at risk of HIV with access to the life changing medication Pre-exposure prophylaxis (PrEP) expanded into major regional centres for the first time.
More than 1300 Victorians have enrolled in an Alfred Health study that will provide unprecedented access to life-changing HIV prevention medication across the state.
Infectious diseases experts at The Alfred have described a drug used to treat alcoholism as a possible ‘game changer' in the pursuit of finding a cure for HIV.